Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)
China
· Delayed Price · Currency is CNY 51.71
+0.27 (0.52%)
Aug 15, 2025, 2:45 PM CST
SHA:688336 Revenue
Sunshine Guojian Pharmaceutical (Shanghai) had revenue of 311.12M CNY in the quarter ending March 31, 2025, with 16.57% growth. This brings the company's revenue in the last twelve months to 1.24B, up 15.29% year-over-year. In the year 2024, Sunshine Guojian Pharmaceutical (Shanghai) had annual revenue of 1.19B with 17.70% growth.
Revenue (ttm)
1.24B
Revenue Growth
+15.29%
P/S Ratio
25.88
Revenue / Employee
1.24M
Employees
995
Market Cap
32.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.19B | 179.53M | 17.70% |
| Dec 31, 2023 | 1.01B | 188.54M | 22.84% |
| Dec 31, 2022 | 825.49M | -103.32M | -11.12% |
| Dec 31, 2021 | 928.81M | 273.80M | 41.80% |
| Dec 31, 2020 | 655.01M | -522.39M | -44.37% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| WuXi AppTec | 41.48B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Aier Eye Hospital Group | 21.81B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |